ICP Parking Lot/Vaccines

Structured Rational for the Paper

1. The Argument Framework

Study of the field

Analysis of the field with basis on Field Research Methodology

1. Overview of Economics of Intellectual Property in Vaccines
2. Give an overall picture of the Vaccines' sector
3. Outputs and Products of the field: data, narratives and tools produced by the Vaccines' sector
4. Legal tools available for and in use by the actors of Vaccines' sector: IP in Vaccines
5. competitive advantages in Vaccines
6. IP Profile of Biggest for-profit companies in Vaccines
7. IP Profile of non-profit companies in Vaccines
8. IP Profile of Universities working in Vaccines
9. IP Profile of Associations in Vaccines
10. Commons based cases in Vaccines
11. Peer-Production Business models in Vaccines
12. Open Business models in Vaccines

Bibliography

• American Society of Law, Medicine & Ethics, Inc., and Boston University American Journal of Law & Medicine, 2009, 35 Am. J. L. and Med.:
  • Highlights
• Follow-On Biologics: Intellectual Property and Innovation Issues

introduces innovation policy issues pertaining to follow-on biologics. @http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf

• Emerging Health Care Issues: Follow-on Biologic Drug Competition

@www.ftc.gov/os/2009/06/P083901biologicsreport.pdf

Navigation

Back to Main Page Back to Biotechnology_-_Genomic_and_Proteomics